Status:
COMPLETED
Views on COVID-19 and Vaccination
Lead Sponsor:
University of Massachusetts, Worcester
Collaborating Sponsors:
National Library of Medicine (NLM)
Conditions:
Covid19
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The goal of this study is to develop evidence-based messages that effectively mitigate concerns of people at risk for not being vaccinated against COVID-19, with the ultimate goal of maximizing vaccin...
Detailed Description
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has rapidly instigated a global pandemic. As of this writing, there are approximately 65 million documented cases of infection worldwid...
Eligibility Criteria
Inclusion
- Adult (age 18 and over) who are members of an online panel (Prolific). Members of this panel joined the panel specifically to receive invitations to participate in research surveys and similar activities.
- Able to complete an online survey in English.
Exclusion
- • None
Key Trial Info
Start Date :
January 12 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2021
Estimated Enrollment :
756 Patients enrolled
Trial Details
Trial ID
NCT04706403
Start Date
January 12 2021
End Date
February 1 2021
Last Update
May 24 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Meyers Health Care Institute
Worcester, Massachusetts, United States, 01605